A new study funded by the U.S. Food and Drug Administration reports that artificial hip implants are more likely to prematurely fail and need replacement for female patients, according to a CBS News story.
The story says researchers at Weill Cornell Medical College in New York City analyzed the results for 35,000 hip implant recipients. They found that women were almost 30 percent more likely than men to need a repeat ...
continue reading...
An editorial in the Newark Star Ledger titled “Another black eye for J&J” says that Johnson & Johnson’s actions with regards to its ASR hip replacement were not only unethical, but would have landed an individual in prison.
Johnson & Johnson recalled the implants, made by subsidiary DePuy Orthopaedics, in 2010 after studies showed that nearly half of them broke down ...
continue reading...A Los Angeles jury has awarded $8.3 million in damages to a man who claims he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopedics division.
The case is the first to go to trial of more than 10,000 involving DePuy’s ASR hip implant. According to a Bloomberg article, analysts predict that all of the lawsuits may end up costing Johnson & Johnson billions of ...
continue reading...
Although a recent study found that hip implants are more likely to fail in women than in men, the study authors emphasized that hip replacement is still a very safe surgery overall.
In analyzing the results for 35,000 hip implant recipients, researchers at Weill Cornell Medical College in New York City found that women were almost 30 percent more likely than men to need a repeat surgery within the first three ...
continue reading...In closing arguments for a trial involving Johnson & Johnson’s all-metal hip implant, a lawyer representing a 65-year-old former prison guard who claims he contracted metal poisoning from the device said the company put profits ahead of patient safety.
The case, which is being heard in Los Angeles, is the first of nearly 11,000 lawsuits about the Johnson & Johnson ASR hip implant to go to trial. The plaintiff is asking ...
continue reading...In 2007, marketing executives with Johnson & Johson’s DePuy Orthopaedics division discussed their concerns about the company’s ASR artificial hip implants leaving ions from toxic metal debris in patients’ bodies.
But according to an article in Bloomberg, their concerns didn’t appear to center on the danger for those patients, so much as how the situation might affect sales.
In fact, it would be another three years before the company recalled the implants ...
continue reading...
